SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-22 |
| Reported value | $932,619,485 |
| Positions | 107 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS - CL B | LGND | COM | $53,809,897 | 170,236 |
| GLOBALSTAR INC. | GSAT | COM | $41,433,513 | 509,700 |
| RED VIOLET INC | RDVT | COM | $36,651,362 | 575,194 |
| VANGUARD TOTAL STOCK MARKET ETF | VTI | COM | $35,916,822 | 97,062 |
| STONEX GROUP, INC. | SNEX | COM | $32,710,266 | 276,036 |
| SUPERNUS PHARMACEUTICALS INC. | SUPN | COM | $28,547,047 | 613,783 |
| VICOR CORP | VICR | COM | $28,453,118 | 74,920 |
| ACUITY, INC. | AYI | COM | $27,857,397 | 73,959 |
| UFP TECHNOLOGIES, INC. | UFPT | COM | $27,843,953 | 105,020 |
| CLEAR SECURE, INC. -CLASS A | YOU | COM | $26,699,240 | 479,082 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.